GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (LTS:0QBO) » Definitions » Price-to-Owner-Earnings

Coloplast AS (LTS:0QBO) Price-to-Owner-Earnings : 38.82 (As of May. 24, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Coloplast AS Price-to-Owner-Earnings?

As of today (2025-05-24), Coloplast AS's share price is kr629.70. Coloplast AS's Owner Earnings per Share (TTM) ended in Mar. 2025 was kr16.22. It's Price-to-Owner-Earnings for today is 38.82.


The historical rank and industry rank for Coloplast AS's Price-to-Owner-Earnings or its related term are showing as below:

LTS:0QBO' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 21.6   Med: 46.33   Max: 86.35
Current: 38.82

During the past 13 years, the highest Price-to-Owner-Earnings of Coloplast AS was 86.35. The lowest was 21.60. And the median was 46.33.


LTS:0QBO's Price-to-Owner-Earnings is ranked worse than
63.48% of 293 companies
in the Medical Devices & Instruments industry
Industry Median: 28.25 vs LTS:0QBO: 38.82

As of today (2025-05-24), Coloplast AS's share price is kr629.70. Coloplast AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was kr20.18. Therefore, Coloplast AS's PE Ratio (TTM) for today is 31.20.

As of today (2025-05-24), Coloplast AS's share price is kr629.70. Coloplast AS's EPS without NRI for the trailing twelve months (TTM) ended in was kr20.49. Therefore, Coloplast AS's PE Ratio without NRI for today is 30.73.

During the past 13 years, Coloplast AS's highest PE Ratio without NRI was 54.83. The lowest was 25.37. And the median was 36.22.


Coloplast AS Price-to-Owner-Earnings Historical Data

The historical data trend for Coloplast AS's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Price-to-Owner-Earnings Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.94 46.27 43.02 43.26 47.94

Coloplast AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.02 44.65 47.94 41.83 44.57

Competitive Comparison of Coloplast AS's Price-to-Owner-Earnings

For the Medical Instruments & Supplies subindustry, Coloplast AS's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Price-to-Owner-Earnings falls into.


;
;

Coloplast AS Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Coloplast AS's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=629.70/16.22
=38.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coloplast AS  (LTS:0QBO) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Coloplast AS Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines